Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Favorable Impact of Serum TERT C228T for Prognosis after Surgical Resection for Liver Cancer.

Oncology - 1 Jan 2023

Akuta Norio, Kawamura Yusuke, Fujiyama Shunichiro, Sezaki Hitomi, Hosaka Tetsuya, Saitoh Satoshi, Kobayashi Mariko, Arase Yasuji, Ikeda Kenji, Suzuki Yoshiyuki, Kumada Hiromitsu, Suzuki Fumitaka

Abstract excerpt

INTRODUCTION: Personalized medicine and molecular therapies with the diagnosis of somatic genetic alterations are expected to be developed for liver cancer. Nevertheless, it is unknown whether a mutation in the telomere reverse transcriptase promoter (TERT C228T) in serum cfDNA might be useful for making prognostic predictions after surgical resection for primary liver cancer. METHODS: This cohort study...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Fetoproteins
Share to Carcinoma, Hepatocellular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatectomy

Share to Liver Neoplasms

Share to Neoplasm Recurrence, Local

Share to Protein Precursors

Share to Prothrombin

Share to Telomerase

Source

Identifiers

PMID: 37651985
DOI: 10.1159/000533303

Genes

TERT
AFP

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Favorable Impact of Serum TERT C228T for Prognosis after Surgical Resection for Liver Cancer.PMID 37651985Read ↗

Serum TERT C228T is an important predictor of non-viral liver cancer with fatty liver disease.Semantic proximity Read ↗

TERT promoter mutation predicts the prognosis value of patients with HBV- related HCC who underwent hepatectomySemantic proximity Read ↗

TERT Promoter Mutation in Serum Cell-Free DNA Is a Diagnostic Marker of Primary Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease.Semantic proximity Read ↗

TERT Promoter Mutations Combined with TP53 Mutations as Potential Biomarkers for Hepatocellular Carcinoma Recurrence and PrognosisSemantic proximity Read ↗

TERT-TP53 mutations: a novel biomarker pair for hepatocellular carcinoma recurrence and prognosisSemantic proximity Read ↗

TERT promoter mutated circulating tumor DNA as a biomarker for prognosis in hepatocellular carcinoma.Semantic proximity Read ↗

Telomerase reverse transcriptase mutations in plasma DNA in patients with hepatocellular carcinoma or cirrhosis: Prevalence and risk factorsSemantic proximity Read ↗

Blood circulating C228T TERT gene promoter mutation is an independent factor for the prognosis of HBV-related hepatocellular carcinoma.Semantic proximity Read ↗

TERT promoter mutations in primary liver tumors.Semantic proximity Read ↗

Geographic and Viral Etiology Patterns of TERT Promoter and CTNNB1 Exon 3 Mutations in Hepatocellular Carcinoma: A Comprehensive ReviewSemantic proximity Read ↗

TERT Mutations Correlated With the Prognosis of Patients With Hepatitis B-Related Hepatocellular Carcinoma Underwent Curative HepatectomySemantic proximity Read ↗

Association of TERT promoter mutations with early recurrence in hepatocellular carcinoma: a subgroup analysis in a Vietnamese cohort.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.